1. Home
  2. HAFN vs HCM Comparison

HAFN vs HCM Comparison

Compare HAFN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAFN
  • HCM
  • Stock Information
  • Founded
  • HAFN 2012
  • HCM 2000
  • Country
  • HAFN Singapore
  • HCM Hong Kong
  • Employees
  • HAFN N/A
  • HCM N/A
  • Industry
  • HAFN
  • HCM Biotechnology: Pharmaceutical Preparations
  • Sector
  • HAFN
  • HCM Health Care
  • Exchange
  • HAFN Nasdaq
  • HCM Nasdaq
  • Market Cap
  • HAFN 2.7B
  • HCM 2.5B
  • IPO Year
  • HAFN N/A
  • HCM N/A
  • Fundamental
  • Price
  • HAFN $5.47
  • HCM $17.27
  • Analyst Decision
  • HAFN Strong Buy
  • HCM Buy
  • Analyst Count
  • HAFN 1
  • HCM 2
  • Target Price
  • HAFN $6.50
  • HCM $23.50
  • AVG Volume (30 Days)
  • HAFN 1.1M
  • HCM 42.1K
  • Earning Date
  • HAFN 08-27-2025
  • HCM 08-07-2025
  • Dividend Yield
  • HAFN 16.72%
  • HCM N/A
  • EPS Growth
  • HAFN N/A
  • HCM N/A
  • EPS
  • HAFN 1.20
  • HCM 0.04
  • Revenue
  • HAFN $2,631,664,000.00
  • HCM $630,201,000.00
  • Revenue This Year
  • HAFN N/A
  • HCM $15.00
  • Revenue Next Year
  • HAFN $1.07
  • HCM $19.91
  • P/E Ratio
  • HAFN $4.38
  • HCM $79.28
  • Revenue Growth
  • HAFN N/A
  • HCM N/A
  • 52 Week Low
  • HAFN $3.61
  • HCM $11.51
  • 52 Week High
  • HAFN $8.26
  • HCM $21.50
  • Technical
  • Relative Strength Index (RSI)
  • HAFN N/A
  • HCM 52.60
  • Support Level
  • HAFN N/A
  • HCM $17.36
  • Resistance Level
  • HAFN N/A
  • HCM $19.50
  • Average True Range (ATR)
  • HAFN 0.00
  • HCM 0.42
  • MACD
  • HAFN 0.00
  • HCM -0.02
  • Stochastic Oscillator
  • HAFN 0.00
  • HCM 30.62

About HAFN Hafnia Limited Common Shares

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Share on Social Networks: